Infusion and Sterile Preparation Article Archive CD from the International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

INFUSION AND STERILE PREPARATIONS

A collection of Journal articles and formulations within one or more related compounding topics.

This archive contains the following articles listed by volume, issue and page number:

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
INFUSION RELATED ARTICLES
Calculations Stockton Shelly J	Sep/Oct 2023 Pg. 410
Comparison of Three Reconstitution Devices: A Simulated Time and Use Study Penoyer Daleen, Giuliano Karen, Middleton Aurea	Mar/Apr 2023 Pg. 169-174
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam	Jul/Aug 2018 Pg. 345-349
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)	Nov/Dec 2016 Pg. 457-458
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE	Jul/Aug 2016 Pg. 328-332
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio	Jul/Aug 2016 Pg. 343-346
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C	May/Jun 2016 Pg. 236-238
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Hecq Jean-Daniel, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M	Nov/Dec 2015 Pg. 521-524
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra	Sep/Oct 2015 Pg. 432-436
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Puertos Enrique, Spencer Melissa	Jul/Aug 2015 Pg. 334-336
Basics of Compounding Sterile Preparations: Nomenclature and Considerations Allen Loyd V Jr	Jul/Aug 2014 Pg. 313-317
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Allen Loyd V Jr	Nov/Dec 2011 Pg. 504
Home Infusion: Overview of the Infusion Patient-Care Process Kennedy Steve	Jul/Aug 2011 Pg. 270-276
Stability of Ertapenem in an Elastomeric Infusion Device Phipps Stephen D, Peacock Gina F, Smith Douglas L	May/Jun 2011 Pg. 252-254
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Jasti Bhaskara R, Saraf Poonam	May/Jun 2011 Pg. 259-261
Home Infusion: Available Vascular Access Devices and Common Therapies Kennedy Steve, Williams LaVonn A	May/Jun 2011 Pg. 183-188
Home Infusion Basics for the Non-Infusion Pharmacist Miron Karen E	Mar/Apr 2011 Pg. 94-100
Home Infusion Accreditation: Another Quality Recognition Branding Tool Canally Sandra C	Sep/Oct 2010 Pg. 360-364
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Tsiouris Maria, Ulmer Marisa, Yurcho James F, Hooper Kevin L, Gui Min	Sep/Oct 2010 Pg. 436-439
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A	Mar/Apr 2008 Pg. 170-173
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Trissel Lawrence A, Zhang Yanping	Sep/Oct 2004 Pg. 398-403
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags Gupta Vishnu D	Sep/Oct 2004 Pg. 404-406
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Newton David W, Trissel Lawrence A	Jul/Aug 2004 Pg. 251-263
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Musami Patrick, Stewart James T, Taylor E Will	May/Jun 2004 Pg. 236-239
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2004 Pg. 136
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Gupta Vishnu D	Mar/Apr 2004 Pg. 153-155
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M	Mar/Apr 2004 Pg. 156-159
PostScription: Cleanroom Standards Fitzpatrick Mike, Goldstein Ken	Mar/Apr 2004 Pg. 160
Hydrochloric Acid 0.1-N Injection Allen Loyd V Jr	Jan/Feb 2004 Pg. 55
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Musami Patrick, Stewart James T, Taylor E Will	Jan/Feb 2004 Pg. 73-76
Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Gupta Vishnu D	Jul/Aug 2003 Pg. 310-312
Phenytoin Injections: From Compounding to Cerebyx Newton David W	Nov/Dec 2002 Pg. 410-413
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1 Chamallas Stanley N, Sullivan Kathleen	Nov/Dec 2002 Pg. 428-432
Total Parenteral Nutrition for Animals Sammarco Domenic A	Sep/Oct 2002 Pg. 328-330
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Rice Stephen P	Mar/Apr 2002 Pg. 120-122
Creating a Productivity Measurement Tool for a Home Infusion Pharmacy Chamallas Stanley N	Jan/Feb 2002 Pg. 24-26
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Kastango Eric S, Hadaway Lynn	Jan/Feb 2002 Pg. 55-57
Ceftazidime 20-mg/mL for Ambulatory Infusion Pump Allen Loyd V Jr	Nov/Dec 2001 Pg. 451
New Perspectives on Vancomycin Use in Home Care, Part 1 Kastango Eric S, Hadaway Lynn	Nov/Dec 2001 Pg. 465-469
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes Storms Meredith L, Stewart James T, Warren Flynn W	Sep/Oct 2001 Pg. 394-396
Assessment of the Stability of Teicoplanin in Intravenous Infusions Galanti Laurence M, Hecq Jean-Daniel, Jeuniau Philippe, Vanbeckbergen Danielle, Jamart Jacques	Sep/Oct 2001 Pg. 397-400
PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor Gupta Vishnu D	Jul/Aug 2001 Pg. 328
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Williams Kimberly Y, Baker Ma	Jan/Feb 2001 Pg. 69-73
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Gupta Vishnu D, Ling Jie	Jan/Feb 2001 Pg. 73-75
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Gupta Vishnu D, Ling Jie	Jan/Feb 2001 Pg. 75-77
Disposable Ambulatory Infusion Devices: A Review - Part 3 Ashworth Lisa D	Nov/Dec 2000 Pg. 442-443
Ambulatory Syringe Infusion Devices: A Review - Part 2 Ashworth Lisa D	Sep/Oct 2000 Pg. 364
Short Communication: Compounding for Implantable Pumps Molitor Richard	Jul/Aug 2000 Pg. 280
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review Ashworth Lisa D	Jul/Aug 2000 Pg. 281-285
Needleless Infusion Systems Allen Loyd V Jr, Mathews Elizabeth	May/Jun 2000 Pg. 183
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration Inagaki Kazuhiro, Miyamoto Yuriko, Kurata Niroko, Nakane Shigeki, Gill Mark A, Nishida Mikio	Mar/Apr 2000 Pg. 150-153
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection Gupta Vishnu D, Bailey RE	Jan/Feb 2000 Pg. 66-68
Electronically Controlled Drug Delivery Kloesel Lawson	Nov/Dec 1999 Pg. 439-440
Compounding Radiolabeled Blood Cells for Diagnostic Imaging Hinkle George H	Nov/Dec 1999 Pg. 443-446
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C Webster Andrew A, English Brett A, McGuire J Michael, Riggs Robert M, Lander Vickie, Buckle Thomas	Sep/Oct 1999 Pg. 412-414
Catheter Occlusion: Causes and Solutions McKinnon Barbara, Lima Hetty A	Sep/Oct 1998 Pg. 342-346
TPN Bulk Compounding from Bulk Drug Substances Chamallas Stanley N	Sep/Oct 1998 Pg. 347-349
The Feasibility and Benefits of TPN in Horses: A Review of the Findings Paoletti James E, Downing Dee, Tormo Vicente J	Sep/Oct 1998 Pg. 351-353
Model Parenteral Nutrition Formulation (Veterinary) Allen Loyd V Jr	Sep/Oct 1998 Pg. 352
Required Documentation for Home Infusion Pharmacies - Compounding Records Lima Hetty A	Sep/Oct 1998 Pg. 354-359
Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids Allen Loyd V Jr	Sep/Oct 1998 Pg. 366
Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids Allen Loyd V Jr	Sep/Oct 1998 Pg. 367
Three-in-One Adult Total Parenteral Nutrition Allen Loyd V Jr	Sep/Oct 1998 Pg. 371
Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump Xu Quanyun A, Trissel Lawrence A	Sep/Oct 1998 Pg. 382-384
Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions Sarver Jeffrey G, Pryka Randy, Alexander Kenneth S, Weinstein Louis, Erhardt Paul W	Sep/Oct 1998 Pg. 385-388
Cleaning, Inspecting and Flow-Accuracy Testing of Ambulatory Pumps Allen Loyd V Jr	Nov/Dec 1997 Pg. 430-431
Home Infusion and Alternative-Site Health Care: The Big Picture Lima Hetty A	Sep/Oct 1997 Pg. 294-297
Continued Growth Predicted for Home Infusion Market Allen Loyd V Jr	Sep/Oct 1997 Pg. 298
Drug Stability and Compatibility: Special Considerations for Home Health Care Lima Hetty A	Sep/Oct 1997 Pg. 301-305
Ambulatory Infusion Pump Review Allen Loyd V Jr	Sep/Oct 1997 Pg. 306-307
Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures Fausel Christopher A, Newton David W, Driscoll David F, Allen Loyd V Jr	Jan/Feb 1997 Pg. 54-59
Return to Top

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
STERILE PREPARATIONS RELATED ARTICLES
New USP Chapters <72> and <86> for Testing Pharmaceuticals for Sterility and Endotoxins Ashworth Lisa D	Mar/Apr 2025 Pg. 116-119
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations	Jan/Feb 2025 Pg. 38-39
Hand and Glove Sanitizing in Sterile Compounding, Part 1 Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R	Nov/Dec 2024 Pg. 475-479
Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Allen Loyd V Jr	Sep/Oct 2024 Pg. 358-362
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura	Sep/Oct 2024 Pg. 383-393
Sterile Basics of Compounding: Repackaging, Part 1 Allen Loyd V Jr	Jul/Aug 2024 Pg. 298-303
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Akers Michael J	May/Jun 2024 Pg. 229-240
Sterile Filtration Akers Michael J	Mar/Apr 2024 Pg. 120-127
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura	Jan/Feb 2024 Pg. 44-55
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations Allen Loyd V Jr	Nov/Dec 2023 Pg. 483-486
Hyaluronidase Injection Allen Loyd V Jr	Nov/Dec 2023 Pg. 491
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Allen Loyd V Jr	Sep/Oct 2023 Pg. 397-409
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures Allen Loyd V Jr	Jul/Aug 2023 Pg. 305-313
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations Allen Loyd V Jr	May/Jun 2023 Pg. 223-229
Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Summers Amy	Mar/Apr 2023 Pg. 114-121
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations Allen Loyd V Jr	Mar/Apr 2023 Pg. 123-139
Aminohippurate Sodium 250 mg/mL Injection Allen Loyd V Jr	Mar/Apr 2023 Pg. 142
Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes de Wilde Sofieke, Crul Mirjam, Breukels Oscar	Mar/Apr 2023 Pg. 154-159
Sterile Basics: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control Summers Amy, Stephens Pat	Jan/Feb 2023 Pg. 39-46
Sterile Basics of Compounding: Contamination Control Strategies, Part 2 Summers Amy	Nov/Dec 2022 Pg. 497-504
Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding) Allen Loyd V Jr	Nov/Dec 2022 Pg. 515
Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Summers Amy	Sep/Oct 2022 Pg. 411-418
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program Summers Amy	Jul/Aug 2022 Pg. 309-315
Three Things You Need to Know Right Now Brunner Scott	May/Jun 2022 Pg. 211-213
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Allen Loyd V Jr	May/Jun 2022 Pg. 219-228
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence	May/Jun 2022 Pg. 248-254
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Allen Loyd V Jr	Mar/Apr 2022 Pg. 118-126
Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation Allen Loyd V Jr	Mar/Apr 2022 Pg. 129-136
Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience Mohammad Insaf, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia	Jan/Feb 2022 Pg. 10-17
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Allen Loyd V Jr	Jan/Feb 2022 Pg. 41-49
Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence	Nov/Dec 2021 Pg. 446-462
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Allen Loyd V Jr	Nov/Dec 2021 Pg. 491-496
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy	Sep/Oct 2021 Pg. 389-395
Expecting the Expected: Planning Considerations for Cleanroom Construction Roberts Patricia A, Kroon Laura	Jul/Aug 2021 Pg. 276-281
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy	Jul/Aug 2021 Pg. 298-302
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Allen Loyd V Jr	Jul/Aug 2021 Pg. 311-317
Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding Zamani Mazdak, Chan Kayin, Wilcox Julie	May/Jun 2021 Pg. 182-186
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Allen Loyd V Jr	May/Jun 2021 Pg. 222-229
PreScription: The Past (-->2020), The Present, and The Future (2021-->) Allen Loyd V Jr	Mar/Apr 2021 Pg. 92
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B	Mar/Apr 2021 Pg. 109-113
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Allen Loyd V Jr	Mar/Apr 2021 Pg. 131-139
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol McKettrick Greg, Yoch Doug	Jan/Feb 2021 Pg. 18-23
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 42
Establishing a Structured Pharmacy Training Program in Sterile Compounding Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq	Nov/Dec 2020 Pg. 460-465
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Allen Loyd V Jr	Nov/Dec 2020 Pg. 473-478
Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol	Sep/Oct 2020 Pg. 358-364
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Allen Loyd V Jr	Sep/Oct 2020 Pg. 406
Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques Bjornstad Matthew, Kosinski Tracy, Burlage Robert	Sep/Oct 2020 Pg. 434-438
Quality Control: Rapid Sterility Testing for Compounding Pharmacies Taylor Andrew	Jul/Aug 2020 Pg. 299-303
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations Allen Loyd V Jr	Jul/Aug 2020 Pg. 305-309
Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter	Jul/Aug 2020 Pg. 346-351
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Allen Loyd V Jr	May/Jun 2020 Pg. 215-220
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Allen Loyd V Jr	Mar/Apr 2020 Pg. 121-126
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Vaughn Stacey R, Radwick Allison	Jan/Feb 2020 Pg. 14-19
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr	Jan/Feb 2020 Pg. 44-50
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators Mulder Kyle	Nov/Dec 2019 Pg. 447-452
How to Qualify Container Closure Systems for Intended Use, Part 1 Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page	Nov/Dec 2019 Pg. 454-461
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R	Nov/Dec 2019 Pg. 467-471
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Allen Loyd V Jr	Nov/Dec 2019 Pg. 478-482
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R	Sep/Oct 2019 Pg. 387-391
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Allen Loyd V Jr	Sep/Oct 2019 Pg. 399-402
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing Allen Loyd V Jr	Jul/Aug 2019 Pg. 299-303
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Allen Loyd V Jr	May/Jun 2019 Pg. 221-228
Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J	May/Jun 2019 Pg. 238-244
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? Allen Loyd V Jr	Mar/Apr 2019 Pg. 123-130
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Martin Matt	Jan/Feb 2019 Pg. 47-49
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Martin Matt	Nov/Dec 2018 Pg. 475-478
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin	Sep/Oct 2018 Pg. 387-398
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt	Sep/Oct 2018 Pg. 401-404
Cysteamine 0.5% Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2018 Pg. 408
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Martin Matt	Jul/Aug 2018 Pg. 303-312
Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding Allen Loyd V Jr	May/Jun 2018 Pg. 206-217
Dorzolamide 2% Ophthalmic Solution Allen Loyd V Jr	May/Jun 2018 Pg. 234
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Allen Loyd V Jr	May/Jun 2018 Pg. 237
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Rhoads Rick	Mar/Apr 2018 Pg. 129-134
Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution Allen Loyd V Jr	Mar/Apr 2018 Pg. 147
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Allen Loyd V Jr	Mar/Apr 2018 Pg. 151
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Kosinski Tracy M, Brown Michael C, Zavala Pedro J	Jan/Feb 2018 Pg. 41-46
Glutamate and Aspartate Cardioplegia Additive Solution Allen Loyd V Jr	Jan/Feb 2018 Pg. 50
Sodium Citrate 9% Nasal Spray for Olfactory Disorders Allen Loyd V Jr	Jan/Feb 2018 Pg. 57
Haloperidol 5-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2017 Pg. 493
Trace Elements Injection 5 Allen Loyd V Jr	Nov/Dec 2017 Pg. 498
Vancomycin 5-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2017 Pg. 499
Basics of Sterile Compounding: Particulate Matter Akers Michael J	Sep/Oct 2017 Pg. 395-404
Acetylcysteine Solutions for Inhalation Allen Loyd V Jr	Sep/Oct 2017 Pg. 408
Etoposide 20-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2017 Pg. 410
Fentanyl Citrate 50-mcg/mL Injection Allen Loyd V Jr	Sep/Oct 2017 Pg. 411
Ioversol Injection Allen Loyd V Jr	Sep/Oct 2017 Pg. 413
Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Allen Loyd V Jr	Sep/Oct 2017 Pg. 415
Tacrolimus 0.3-mg/mL Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2017 Pg. 416
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K	Sep/Oct 2017 Pg. 426-429
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M	Sep/Oct 2017 Pg. 436-439
Component Selection for Sterile Compounding Dilzer Richard H	Jul/Aug 2017 Pg. 277-280
Basics of Sterile Compounding: Excipients Used in Injections Akers Michael J	Jul/Aug 2017 Pg. 301-308
Reteplase Injection Allen Loyd V Jr	Jul/Aug 2017 Pg. 317
Tacrolimus 0.06% Ophthalmic Drops Allen Loyd V Jr	Jul/Aug 2017 Pg. 319
Torsemide 10-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2017 Pg. 320
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding Ligugnana Roberto	May/Jun 2017 Pg. 182-190
Microbiologic Testing for 503A Sterile-Compounding Pharmacies Mixon William, Roth Abby	May/Jun 2017 Pg. 193-203
Basics of Sterile Compounding: Manipulating Peptides and Proteins Akers Michael J	May/Jun 2017 Pg. 223-228
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
Accuracy Considerations in Sterile Compounding Akers Michael J	Mar/Apr 2017 Pg. 133-142
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers McCluskey Susan V, Kirkham Kylian, Munson Jessica M	Mar/Apr 2017 Pg. 150-153
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Akers Michael J	Jan/Feb 2017 Pg. 47-56
Infliximab 1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2017 Pg. 62
Tetracaine Hydrochloride 0.5% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2017 Pg. 64
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr	Nov/Dec 2016 Pg. 495-500
Flumazenil 0.1-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2016 Pg. 509
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Allen Loyd V Jr	Sep/Oct 2016 Pg. 399-404
Inamrinone 5-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2016 Pg. 408
Tromethamine Injection Allen Loyd V Jr	Sep/Oct 2016 Pg. 415
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Noorian Shaun, Vahedi Navid	Jul/Aug 2016 Pg. 283-292
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Akers Michael J	Jul/Aug 2016 Pg. 307-314
Dolasetron Mesylate 20-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2016 Pg. 318
Gatifloxacin 0.5% Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 319
Plasmingen and Hyaluronate Sodium Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 325
Scopolamine Hydrobromide 0.25% Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 326
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Akers Michael J	May/Jun 2016 Pg. 217-222
Carboplatin 50-mg/mL Injection Allen Loyd V Jr	May/Jun 2016 Pg. 226
Cefotetan Disodium Injection Allen Loyd V Jr	May/Jun 2016 Pg. 227
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Allen Loyd V Jr	May/Jun 2016 Pg. 228
Sodium Nitroprusside 25-mg/mL Injection Allen Loyd V Jr	May/Jun 2016 Pg. 234
Root Cause Analysis, Part 2: Sterile Compounding Cabaleiro Joe, Jackson Kathleen	Mar/Apr 2016 Pg. 99-104
Formulation and Stability of Solutions Akers Michael J	Jan/Feb 2016 Pg. 41-45
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Allen Loyd V Jr	Jan/Feb 2016 Pg. 51
Thrombin 1,000 Units/mL Topical Solution, Sterile Allen Loyd V Jr	Jan/Feb 2016 Pg. 54
Tropicamide 1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2016 Pg. 55
Vancomycin 5% and Amikacin 2% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2016 Pg. 56
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Akers Michael J	Nov/Dec 2015 Pg. 491-500
Cefepime Hydrochloride 100-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2015 Pg. 505
Cefotaxime 100-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2015 Pg. 506
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Allen Loyd V Jr	Nov/Dec 2015 Pg. 507
Estradiol Valerate 40-mg/mL in Oil Injection Allen Loyd V Jr	Nov/Dec 2015 Pg. 509
Levetiracetam 100-mg/mL Injection (Concentrate) Allen Loyd V Jr	Nov/Dec 2015 Pg. 510
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Donnelly Ronald F	Sep/Oct 2015 Pg. 383-386
Sterile Filtration Akers Michael J	Sep/Oct 2015 Pg. 393-401
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura	Jul/Aug 2015 Pg. 268-278
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Akers Michael J	Jul/Aug 2015 Pg. 315-320
Ammonium Molybdate 25-mcg/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 324
Cytarabine 50-mg/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 328
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Allen Loyd V	Jul/Aug 2015 Pg. 329
Oxytocin 10-units/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 330
Phytonadione 2-mg/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 331
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities Weller Tom, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan	May/Jun 2015 Pg. 182-192
Quality Assurance and Quality Control, Part 2 Akers Michael J	May/Jun 2015 Pg. 215-221
Basics of Sterile Compounding: Contamination Control Akers Michael J	May/Jun 2015 Pg. 232-238
Physostigmine Salicylate 1-mg/mL Injection Allen Loyd V Jr	May/Jun 2015 Pg. 246
Scopolamine Hydrobromide -.4-mg/mL Injection Allen Loyd V Jr	May/Jun 2015 Pg. 247
Protocol of Blood Serum Eye Drops Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos	May/Jun 2015 Pg. 252-260
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin	May/Jun 2015 Pg. 261-267
New England Compounding Center Indictment Cabaleiro Joe	Mar/Apr 2015 Pg. 94-102
Quality Assurance and Quality Control, Part 1 Akers Michael J	Mar/Apr 2015 Pg. 121-124
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Akers Michael J	Mar/Apr 2015 Pg. 127-138
Aminohippurate Sodium 200-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 143
L-Cysteine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 146
Morrhuate Sodium 5% Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 147
Pancuronium Bromide 1-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 149
Physostigmine Salicylate 1-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 150
Trypan Blue 0.06% Ophthalmic Solution Allen Loyd V Jr	Mar/Apr 2015 Pg. 151
Basics of Sterile Compounding: Aseptic Processing Akers Michael J	Jan/Feb 2015 Pg. 49-56
Cisplatin 1-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 62
Daunorubicin 5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 63
Erythromycin 50-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 64
Hydralazine Hydrochloride 20-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 65
Phentolamine Mesylate 5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 69
PreScription: "Named Formulas" Database Available Allen Loyd V Jr	Nov/Dec 2014 Pg. 444
Depyrogenation Options for the Compounding Cleanroom Weller Tom, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce	Nov/Dec 2014 Pg. 446-454
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Akers Michael J	Nov/Dec 2014 Pg. 479-484
Dexmedetomidine 100 mcg/mL Injection Allen Loyd V Jr	Nov/Dec 2014 Pg. 495
Leucovorin 10-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2014 Pg. 497
Levocarnitine 200-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2014 Pg. 498
Methylene Blue 10-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2014 Pg. 500
Oxacillin Sodium 167-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2014 Pg. 502
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Palma Elisabetta, Bufarini Celestino	Sep/Oct 2014 Pg. 358-364
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know Lanze Amanda, Rudner Shara	Sep/Oct 2014 Pg. 397-399
Azithromycin 100-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 408
Dexpanthenol 250-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 410
Ephedrine Sulfate 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 411
Fluorescein 100-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 412
Indocyanine green 2.5-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 413
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Johnson Kain, Sully Andrew, Anthenat Bruce	Jul/Aug 2014 Pg. 270-276
Basics of Compounding Sterile Preparations: Nomenclature and Considerations Allen Loyd V Jr	Jul/Aug 2014 Pg. 313-317
Atracurium Besylate 10-mg/mL Injection, Preserved Allen Loyd V Jr	Jul/Aug 2014 Pg. 322
Calcitriol 1-mcg/mL Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 324
Chloramphenicol 100-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 325
Indigo Carmine Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 329
Propranolol Hydrochloride 1-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 330
Zinc 1-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 331
Bupivacaine Hydrochloride 0.5% Injection Allen Loyd V Jr	May/Jun 2014 Pg. 234
Lidocaine Hydrochloride 1% Injection Allen Loyd V Jr	May/Jun 2014 Pg. 237
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Marks Zach	Mar/Apr 2014 Pg. 94-99
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Vu Nicole, Nguyen Devin, Kupiec Thomas C	Mar/Apr 2014 Pg. 123-130
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Allen Loyd V Jr	Mar/Apr 2014 Pg. 131-134
Fludarabine Phosphate 25-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 143
Mecasermin 10-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 144
Methylprednisolone 40-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 145
Polymixin B Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 146
Rocuronium Bromide 10-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 147
Selenium 40-mcg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 149
Sincalide 1-mcg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 150
Testosterone Enanthate 200-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 151
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc	Jan/Feb 2014 Pg. 6-12
Determination of Risk for Sterile Preparations Freedman ben-Horin Shimon, Rousso Tamaro	Jan/Feb 2014 Pg. 30-34
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Hyde Tiffany D	Jan/Feb 2014 Pg. 46-52
Basics of Sterile Compounding: Bubble Point Testing Thoma Laura	Jan/Feb 2014 Pg. 54-57
Aztreonam Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 60
Bumetanide 0.25-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 61
Droperidol 2.5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 62
Potassium Chloride 2-mEq/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 67
Procainamide Hydrochloride 100-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 68
Vasopressin 20-units/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 69
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies Brensel Robert, Brensel Scott, Ng Amy	Nov/Dec 2013 Pg. 465-475
Benztropine Mesylate 1-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2013 Pg. 498
Cefazolin 250-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2013 Pg. 499
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Allen Loyd V Jr	Nov/Dec 2013 Pg. 502
Dihydroergotamine Mesylate 1-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2013 Pg. 503
Compounding Pharmacies: Before and After an Inspection Kulkarni Darshan, Ricketts Samantha	Sep/Oct 2013 Pg. 358-362
Acyclovir 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 414
Aminocaproic Acid 250-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 415
Clindamycin 150-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 416
Fluorouracil 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 417
Hydroxyzine Hydrochloride 25-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 418
Indomethacin 1-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 419
Mesna 100-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 420
Methotrexate 25-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 421
Phenylephrine Hydrochloride 10-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 422
Terbutaline Sulfate 1-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 423
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Newton David W	Jul/Aug 2013 Pg. 283-288
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations McElhiney Linda F	Jul/Aug 2013 Pg. 307-311
Allopurinol Sodium 4-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 328
Amikacin Sulfate 250-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 329
Dacarbazine 200-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 330
Ketamine 50-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 331
Methohexital Sodium 500-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 332
Metoprolol Tartrate 1-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 333
Succinylcholine Chloride 50-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 335
Decontamination Technology: The Missing Element Rahe Hank	May/Jun 2013 Pg. 193-199
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy	May/Jun 2013 Pg. 238-246
Sterilization of Compounded Parenteral Products: Verification of Autoclaves Rahe Hank	Mar/Apr 2013 Pg. 94-98
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program Griffiths Tricia, Connors Anne	Mar/Apr 2013 Pg. 130-134
Basics of Compounding: Repackaging, Part 2 Allen Loyd V Jr	Mar/Apr 2013 Pg. 136-140
Adenosine 3-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 144
Alcohol Dehydrated Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 145
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate Allen Loyd V Jr	Mar/Apr 2013 Pg. 147
Cyanocobalamin 1000-mcg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 148
Dexrazoxane 1-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 149
Meropenem 50-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 150
Paclitaxel 6-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 151
Thiotepa 15-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 152
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy	Mar/Apr 2013 Pg. 168-174
Basics of Compounding: Repackaging, Part 1 Allen Loyd V Jr	Jan/Feb 2013 Pg. 54-60
Desmopressin 4-mcg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 64
Dobutamine 10-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 65
Granisetron 1-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 66
Ibuprofen 10-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 67
Mepivacaine Hydrochloride 1% Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 68
Milrinone 0.2-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 69
Neostigmine Methylsulfate 0.5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 70
Nicardipine Hydrochloride Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 71
Octreotide 50-mcg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 72
Testosterone Cypionate 100-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 73
Aminophylline 25-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 500
Ammonium Chloride 5-mEq/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 501
Azathioprine 10-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 502
Copper 0.4-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 503
Dipyridamole 5-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 504
Dopamine Hydrochloride 80-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 505
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Allen Loyd V Jr	Nov/Dec 2012 Pg. 506
Papaverine Hydrochloride 30-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 507
Valproate Sodium 100-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 508
Vercuronium Bromide 1-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 509
Metronidazole 5-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 425
Doxapram Hydrochloride 20-mg/mL injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 418
Enalaprilat 1.25-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 419
Esmolol Hydrochloride 10-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 420
Fluconazole 2-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 421
Haloperidol 50-mg/mL in Oil Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 422
Meperidine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 423
Methocarbamol 100-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 424
Nalbuphine Hydrochloride 10-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 426
Oxymorphone Hydrochloride 1-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 427
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease McElhiney Linda F	May/Jun 2012 Pg. 190-195
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Cabaleiro Joe	Jan/Feb 2012 Pg. 86-87
Misinterpretation of United States Pharmacopeia Chapter <797> McElhiney Linda F	Jan/Feb 2012 Pg. 6-10
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian	Sep/Oct 2011 Pg. 390-407
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions Schnatz Rick, Hernandex-Cardoso Antonio	May/Jun 2011 Pg. 224-232
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug	Mar/Apr 2011 Pg. 133-144
PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals Allen Loyd V Jr, Menighan Thomas E	Jan/Feb 2011 Pg. 4
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management Robinson Marian	Jan/Feb 2011 Pg. 20-26
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations Cooper James F	Jan/Feb 2011 Pg. 49-54
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2 Cooper James F, Chakrabarty Kaushik, McGuire Jason, Zolner William J, Jones Vann, Hedman Hilary	Nov/Dec 2010 Pg. 493-506
Home Infusion: Overcoming the Barriers to Entry Franklin David M	Nov/Dec 2010 Pg. 450-455
Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device Kennedy Steve, Siefert Lisa Linn, Lange Matt	Sep/Oct 2010 Pg. 370-372
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 Dubczak John, Latta Kenneth S, Hedman Hilary, Smith Donald R	Sep/Oct 2010 Pg. 407-414
PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board Pharmacy Compounding Accreditation Board	Sep/Oct 2010 Pg. 440-441
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals Menighan Thomas E	Jul/Aug 2010 Pg. 268
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together McElhiney Linda F	Jul/Aug 2010 Pg. 270-274
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters Dawson Michael E	Jul/Aug 2010 Pg. 317-320
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Okeke Claudia C, Allen Loyd V Jr	Jul/Aug 2010 Pg. 328-331
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Okeke Claudia C, Allen Loyd V Jr	May/Jun 2010 Pg. 232-238
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests Allen Loyd V Jr, Okeke Claudia C	Mar/Apr 2010 Pg. 142-149
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Khondkar Dristi, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin	Mar/Apr 2010 Pg. 160-164
Ophthalmic Toning-Lubricating Drops Allen Loyd V Jr	Jan/Feb 2010 Pg. 70
An Academic Practice Partnership: An Innovative Course in Advanced Compounding Hale Katherine S, Hammer Dana P, Needham Shawn, Lawhorn Michelle Gaster	Jan/Feb 2010 Pg. 48-53
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control Okeke Claudia C, Allen Loyd V Jr	Jan/Feb 2010 Pg. 60-64
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Mixon William, Angelle Patricea (Patsy), Chang Richard I	Nov/Dec 2009 Pg. 506-515
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole	Nov/Dec 2009 Pg. 540-543
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures Okeke Claudia C, Allen Loyd V Jr	Nov/Dec 2009 Pg. 546-553
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Bailey Caroline, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole	Nov/Dec 2009 Pg. 564-568
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing Okeke Claudia C, Allen Loyd V Jr	Sep/Oct 2009 Pg. 420-426
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Mixon Bill, Ille Gary	Jul/Aug 2009 Pg. 290-294
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Okeke Claudia C, Allen Loyd V Jr	Jul/Aug 2009 Pg. 322-329
PostScription: Compounding Pharmacy in Puerto Rico Lopez Marisol	Jul/Aug 2009 Pg. 350-351
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting McElhiney Linda F	Jul/Aug 2009 Pg. 300-310
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Allen Loyd V Jr, Okeke Claudia C	May/Jun 2009 Pg. 234-238
Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797> McElhiney Linda F	Mar/Apr 2009 Pg. 94-98
Tips for Cleanroom Construction and Renovation Mixon William, Huffman Lanny	Mar/Apr 2009 Pg. 100-104
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations Latta Kenneth S, Howard Betty, Gordon Ken, Foster Lisa, Nichols Larry, Floyd Dan B, Winters Martell, Bryans Trabue	Mar/Apr 2009 Pg. 106-119
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods Allen Loyd V Jr, Okeke Claudia C	Mar/Apr 2009 Pg. 146-150
Acidified Sodium Hypochlorite for Antisepsis and Disinfection Allen Loyd V Jr	Mar/Apr 2009 Pg. 152
Quality Control Analytical Methods: Testing of Electrolytes Solutions Vu Nicole	Jan/Feb 2009 Pg. 53-55
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Allen Loyd V Jr, Okeke Claudia C	Jan/Feb 2009 Pg. 56-62
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Allen Loyd V Jr, Okeke Claudia C	Sep/Oct 2008 Pg. 440-443
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Trissel Lawrence A	Nov/Dec 2008 Pg. 524-528
Glycerin, Sterile Allen Loyd V Jr	Nov/Dec 2008 Pg. 542
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr	Nov/Dec 2008 Pg. 530-536
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Allen Loyd V Jr, Okeke Claudia C	Jul/Aug 2008 Pg. 344-353
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane	Jul/Aug 2008 Pg. 321-327
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Allen Loyd V Jr, Okeke Claudia C	May/Jun 2008 Pg. 252-257
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Kastango Eric S	May/Jun 2008 Pg. 216-229
Dilution and Compounding of Ziconotide for Intrathecal Administration Buchta Tony, Fakata Keri, Stuart William	May/Jun 2008 Pg. 200-207
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Odegard Russell D	Mar/Apr 2008 Pg. 130-135
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Allen Loyd V Jr, Okeke Claudia C	Mar/Apr 2008 Pg. 136-144
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Allen Loyd V Jr, Okeke Claudia C	Jan/Feb 2008 Pg. 54-60
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study Peters Gregory F, McKeon Marghi R, Nerbun Richard G	Nov/Dec 2007 Pg. 450-470
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics Allen Loyd V Jr, Okeke Claudia C	Nov/Dec 2007 Pg. 492-499
Calculations: High-Technology Compounding and Investigational Dispensing Webb Sheldon D, Stockton Shelly J	Nov/Dec 2007 Pg. 500-501
Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance Allen Loyd V Jr	Nov/Dec 2007 Pg. 502-503
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests Kupiec Thomas C	Sep/Oct 2007 Pg. 400-403
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C	Sep/Oct 2007 Pg. 404-410
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Allen Loyd V Jr	Jul/Aug 2007 Pg. 328
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Okeke Claudia C	Jul/Aug 2007 Pg. 302-305
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Allen Loyd V Jr, Okeke Claudia C	Jul/Aug 2007 Pg. 314-323
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Allen Loyd V Jr	Jul/Aug 2007 Pg. 335
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 Allen Loyd V Jr, Okeke Claudia C	May/Jun 2007 Pg. 230-236
Quality Control Analytical Methods: The Quality of Sterility Testing McGuire Jason, Kupiec Thomas C	Jan/Feb 2007 Pg. 52-55
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Benischek Rita L	Nov/Dec 2006 Pg. 428-433
Quality-Control Analytical Methods: Sterility Failure Investigations Venti Eden M	Sep/Oct 2006 Pg. 372-375
Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces Acosta W Renee, Salzman Robert D	Jul/Aug 2006 Pg. 277-280
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist Zolner William J	Jul/Aug 2006 Pg. 281-284
Aseptic Compounding in New Zealand and the Use of Still Air Boxes Gargiulo Derryn, Kairuz Therese Eileen	Jul/Aug 2006 Pg. 293-295
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations Douglass Kate	Jul/Aug 2006 Pg. 253-261
Putting the Science Back into the "Art and Science" of Compounding Kastango Eric S	Jul/Aug 2006 Pg. 263-268
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Reed-Kane Dana, Kirshbaum Karen	May/Jun 2006 Pg. 165-171
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor Fields Shannon W	May/Jun 2006 Pg. 172
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Tran Tuan, Kupiec Thomas C, Trissel Lawrence A	May/Jun 2006 Pg. 202-204
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions Allen Loyd V Jr	May/Jun 2006 Pg. 218
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Wagner James T	May/Jun 2006 Pg. 208-211
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist Jeffrey Megan	Mar/Apr 2006 Pg. 113-119
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Dawson Michael F	Jan/Feb 2006 Pg. 36-39
How'd They Do That? Roberts Jerrod L	Jan/Feb 2006 Pg. 46-49
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Nguyen-Xuan Tho, Griffiths William, Kern Christian, Van Gessel Elisabeth, Bonnabry Pascal	Jan/Feb 2006 Pg. 69-73
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2005 Pg. 390
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2005 Pg. 394
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) Allen Loyd V Jr	Sep/Oct 2005 Pg. 395
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Newton David W	Mar/Apr 2005 Pg. 127-130
PostScription: Experts Everywhere Rahe Hank	Mar/Apr 2005 Pg. 167
USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing Caputo Ross A, Huffman Anne, Reich Robert	Jan/Feb 2005 Pg. 11-13
Using ACDs in the Practice of Pharmacy Kastango Eric S	Jan/Feb 2005 Pg. 15-21
USP Chapter <797> and Preparing for a JCAHO Survey McElhiney Linda F	Jan/Feb 2005 Pg. 23-28
Questions and Answers: USP Chapter <797> and JCAHO Compliance Allen Loyd V Jr	Jan/Feb 2005 Pg. 29-31
A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In? Vandenbroucke Johan, Rahe Hank	Jan/Feb 2005 Pg. 33-35
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations Kupiec Thomas C	Jan/Feb 2005 Pg. 47-49
Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? Rahe Hank	Jan/Feb 2005 Pg. 53-56
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Allen Loyd V Jr	Nov/Dec 2004 Pg. 466-467
Calculations Prince Shelly J	Nov/Dec 2004 Pg. 468
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations Allen Loyd V Jr	Nov/Dec 2004 Pg. 479-485
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating Kastango Eric S	Sep/Oct 2004 Pg. 393-397
PreScription - Categories of Pharmaceutial Compounding Allen Loyd V Jr	Jul/Aug 2004 Pg. 242
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Newton David W, Trissel Lawrence A	Jul/Aug 2004 Pg. 251-263
Clonidine HCl 1.5-mg/mL Injection Allen Loyd V Jr	May/Jun 2004 Pg. 216
Fluorouracil 1% Ophthalmic Solution Allen Loyd V Jr	May/Jun 2004 Pg. 217
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Allen Loyd V Jr	May/Jun 2004 Pg. 220
Testosterone Propionate 100-mg/mL in Oil Injection Allen Loyd V Jr	May/Jun 2004 Pg. 222
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Xu Quanyun A, Trissel Lawrence A, Pham Lien	May/Jun 2004 Pg. 228-230
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Trissel Lawrence A, Zhang Yanping	May/Jun 2004 Pg. 231-235
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Musami Patrick, Stewart James T, Taylor E Will	May/Jun 2004 Pg. 236-239
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Rahe Hank	Mar/Apr 2004 Pg. 89-94
Netilmicin 0.455% Ophthalmic Solution Allen Loyd V Jr	Mar/Apr 2004 Pg. 138
Pyridoxine HCl 100-mg/mL Injection, Preservative Free Allen Loyd V Jr	Mar/Apr 2004 Pg. 139
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Gupta Vishnu D	Mar/Apr 2004 Pg. 153-155
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M	Mar/Apr 2004 Pg. 156-159
PostScription: Cleanroom Standards Fitzpatrick Mike, Goldstein Ken	Mar/Apr 2004 Pg. 160
Glycerin 50% Injection Allen Loyd V Jr	Jan/Feb 2004 Pg. 54
Hydrochloric Acid 0.1-N Injection Allen Loyd V Jr	Jan/Feb 2004 Pg. 55
Phenol 5%-in-Oil Injection Allen Loyd V Jr	Jan/Feb 2004 Pg. 57
Vancomycin HCl and Heparin Sodium Injection Allen Loyd V Jr	Jan/Feb 2004 Pg. 60
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Musami Patrick, Stewart James T, Taylor E Will	Jan/Feb 2004 Pg. 73-76
Containment of Hazardous Particulates in the Compounding Pharmacy Allen Loyd V Jr	Jul/Aug 2003 Pg. 281-285
Stability of Amikacin Sulfate in AutoDose Infusion System Bags Zhang Yanping, Trissel Lawrence A	May/Jun 2003 Pg. 230-232
Autoclaves for the Sterilization of Compounded Parenteral Products Rahe Hank	Mar/Apr 2003 Pg. 114-116
Technology Spotlight: Barrier Isolators Moussa Magdy, Rahe Hank, Lo Katharine	Jan/Feb 2003 Pg. 42-43
Comparison of Endotoxin Testing Methods for Pharmaceutical Products Joiner Timothy J, Kraus Paul F, Kupiec Thomas C	Nov/Dec 2002 Pg. 408-409 View Sample
Book Review: Sterile Compounding Reed-Kane Dana	Nov/Dec 2002 Pg. 414
Sterile Compounding of Respiratory Inhalation Solutions Roberts Rob, Moore Eddie	Nov/Dec 2002 Pg. 415-417
Benzalkonium Chloride 1:750 Solution for Cold Disinfection Allen Loyd V Jr	Nov/Dec 2002 Pg. 448
Furosemide 10-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2002 Pg. 453
Phenobarbital Sodium 130-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2002 Pg. 457
Cleaning and Disinfection Allen Loyd V Jr	Nov/Dec 2002 Pg. 466-467
Sterilization of Talc for Use in Pleurodesis Fehr Richard, Henke Michelle, Ashworth Lisa D	Mar/Apr 2002 Pg. 140-141
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Kastango Eric S, Hadaway Lynn	Jan/Feb 2002 Pg. 55-57
Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures Karolchyk Scott	Nov/Dec 2001 Pg. 422-423
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution Allen Loyd V Jr	Nov/Dec 2001 Pg. 455
New Perspectives on Vancomycin Use in Home Care, Part 1 Kastango Eric S, Hadaway Lynn	Nov/Dec 2001 Pg. 465-469
Cross-contamination in Porcelain Mortars Bauer-Brandl Annette, Falck Astrid, Ingebrigtsen Lars, Nilsen Cathrina	Nov/Dec 2001 Pg. 476-479
Quality Assurance for Sterile Products Kastango Eric S, Douglass Kate	Jul/Aug 2001 Pg. 246-253
Sterile Compounding with Barrier-Isolation Technology Rahe Hank	Jul/Aug 2001 Pg. 254-258
Bacterial Endotoxins and Pyrogens Jones Marty	Jul/Aug 2001 Pg. 259-263
Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices" Okeke Claudia C, Barletta Frank, Newton David W, Allen Loyd V Jr	Jul/Aug 2001 Pg. 265-267
Sterile Compounding: Excerpts from the Reviews of Current Published Literature MacCara Mary E	Jul/Aug 2001 Pg. 278-279
Analytical Testing Facilities and Products Hudson Sonora	Jul/Aug 2001 Pg. 284-286
Maintenance of the Cleanroom Allen Loyd V Jr	Jul/Aug 2001 Pg. 313
Sterile-Product Preparations: Mix or Buy? Kastango Eric S	Jan/Feb 2001 Pg. 59-63
Short Communication: Compounding for Implantable Pumps Molitor Richard	Jul/Aug 2000 Pg. 280
Dry Heat Sterilization of Parenteral Oil Vehicles Kupiec Thomas C, Matthews Parrish, Ahmad Riaz	May/Jun 2000 Pg. 223-224
Compounding Intrathecal Medications Vidrine Eric	Jan/Feb 2000 Pg. 24-25
Standard Operating Procedure: Quality Assessment for Injectable Solutions Allen Loyd V Jr	Sep/Oct 1999 Pg. 406-407
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding Kastango Eric S, Douglass Kate	Jul/Aug 1999 Pg. 253-258
Sterilization and Depyrogenation Principles and Methods Akers Michael J	Jul/Aug 1999 Pg. 263-269
Sterile Product Compounding: A Comparison of ASHP and USP Guidelines Lima Hetty A	Jul/Aug 1999 Pg. 270-273
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital English Brett A, Riggs Robert M, Webster Andrew A, Benner Kimberly W	Jan/Feb 1999 Pg. 64-66
Testing for Bacterial Endotoxins Jelinek Todd	Sep/Oct 1998 Pg. 379
Ophthalmic Compounding: Techniques for Achieving Sterility Leiter Charles W	May/Jun 1998 Pg. 189
Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations Allen Loyd V Jr	May/Jun 1998 Pg. 192-195
An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate Rice Stephen P	May/Jun 1998 Pg. 214-215
General Aseptic Procedures Used at a Laminar Airflow Workbench Allen Loyd V Jr	May/Jun 1998 Pg. 242
Return to Top